AgelessRx Broadens GLP-1 Weight Care Options to Advance Longevity-First Healthcare
ANN ARBOR, Mich.--(BUSINESS WIRE)-- AgelessRx, a pioneer in longevity and telehealth solutions, is expanding its suite of GLP-1 offerings to better serve customers seeking sustainable, medically guided solutions. The updated offering includes access to Zepbound® via LillyDirect® and the introduction of Compounded Liraglutide + B12.
This expansion reflects AgelessRx's mission to make science-backed, personalized longevity care more accessible, offering a range of clinically appropriate GLP-1 therapies that support better metabolic health and, in turn, potentially improve lifespan and healthspan.
Weight is one of the most modifiable risk factors affecting healthy aging. Elevated BMI is strongly associated with reduced life expectancy, insulin resistance, and age-related disease. For people who've struggled to achieve a lower BMI through lifestyle alone, GLP-1s have been a promising solution.
The GLP-1 category is projected to exceed $322.85 billion globally by 2034, with rapid growth at 21.3% CAGR, driven by public demand for obesity and metabolic health solutions that target the biology behind weight gain. As a longevity-first platform, AgelessRx is uniquely positioned to guide customers through safe, personalized use of these therapies as part of a broader preventative care model.
AgelessRx clinicians will evaluate eligibility and, if appropriate, prescribe Zepbound® for fulfillment via LillyDirect®, Eli Lilly's direct-to-patient pharmacy. AgelessRx will provide full prescription management and clinical oversight for $50/month, including titration guidance, side-effect monitoring, as well as ongoing care and education to provide an additional layer of longevity-focused support. If eligible, patients can access Zepbound® single-dose vials directly from LillyDirect®, starting at $349/month. AgelessRx is not affiliated with Eli Lilly or LillyDirect® and serves solely as the prescribing and care coordination provider to support patients through their treatment.
Recent topline results from the SURMOUNT-5 trial show the impact of Zepbound® (tirzepatide):
−20.2% average weight reduction with tirzepatide compared to -13.7% with semaglutide
47% greater relative reduction in weight
Over 31% of patients on tirzepatide achieved ≥25% weight loss
While full peer-reviewed results are pending, these findings reinforce growing evidence that dual GIP/GLP-1 receptor agonists like tirzepatide may offer significant metabolic benefits.
In addition to supporting access to Zepbound® via LillyDirect®, AgelessRx has also introduced Compounded Liraglutide + B12, a daily GLP-1 injectable. These two new treatments join several other metabolic health solutions, all of which are prescribed following a comprehensive evaluation and personalized plan, providing eligible customers with a diverse range of treatment options based on affordability, clinical fit, safety, and overall health goals.
For additional information about AgelessRx, please visit agelessrx.com.
*AgelessRx has no affiliation or partnership with Eli Lilly or LillyDirect®. AgelessRx's role is to provide clinical evaluation and prescription management for patients who meet the medical criteria for Zepbound®. Medication fulfillment is handled solely by LillyDirect®.
About AgelessRx
AgelessRx is at the forefront of the longevity revolution, offering clinically validated, cutting-edge solutions and preventive treatments aimed at extending life expectancy and enhancing quality of life. AgelessRx also continues to advance the field of longevity science by conducting ongoing research and clinical trials. Through its online platform, AgelessRx provides easy access to innovative healthcare services, with an emphasis on customer satisfaction, affordability, and the pursuit of a future where extended healthspan is a reality for everyone. Follow AgelessRx on Instagram, X, and Facebook.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
VITALITY ANNOUNCES FOURTH QUARTER AND YEAR END RESULTS
TSXV Trading Symbol: VPI VANCOUVER, BC, June 2, 2025 /CNW/ - Vitality Products Inc. (TSXV: VPI) (the "Company" or "Vitality"), a manufacturer, marketer and distributor of premium vitamins and supplements, is pleased to report its financial results for the fourth quarter and the fiscal year ending January 31, 2025 and highlights: 37% sales increase in Q4 72% gross margin in Q4 46% decrease in annual net loss and 62% decrease in Q4 net loss Sales of the Company's premium natural health products for the three months ended January 31, 2025 increased 37% to $235,278 (2024 - $171,704). The Company's gross margin on its sales for the three months ended January 31, 2025 was $170,314 or 72% of sales (2024 - $125,794 or 73% of sales) as the Company continues to have strong gross margins due to the uniqueness of its natural health products. The financial results of the Company for the three months ended January 31, 2025 show a net loss of $11,388 or $0.00 per share compared to a net loss of $30,020 or $0.00 per share for the same period last year. The Company's general selling expenses for the three months ended January 31, 2025 increased to $35,799 (2024 - $29,932). The Company's general and administrative expenses for the three months ended January 31, 2025 increased to $142,320 (2024 - $123,683). The Company is focused on expanding distribution and growing sales in Canada and the United States while maintaining its overall operating efficiencies. The financial results of the Company for its year ended January 31, 2025 show a net loss of $146,063 or $0.00 per share compared to a net loss of $269,038 or $0.01 per share for the same period last year. Sales for the year ended January 31, 2025 increased 1% to $792,773 (2024 - $787,223). The Company's general selling expenses for the year ended January 31, 2025 decreased to $124,399 (2024 - $197,964). The Company's general and administrative expenses for the year ended January 31, 2025 decreased to $578,830 (2024 - $626,392). The Company continues to evaluate, research and develop new products for future distribution including exploring new markets for its products. Management has explored multiple business opportunities for international sales, potential acquisition or mergers with similar businesses including AI, digital health applications, and product lines. Management continues to look at opportunities to grow the business. More information about the Company is available on and The Company's audited financial statements and management's discussion and analysis for the years ended January 31, 2025 and 2024 are available on SEDAR+ at About Vitality VITALITY® is an award-winning line of clean vitamins and supplements, marketed to natural health retailers and health and wellness conscious consumers. Manufactured in Canada and currently sold in natural health stores and online, the products are non-GMO and third party tested for quality. Following the proven success of the line through repeat orders and same store sales growth, the Company is focused on expanding distribution and growing sales in-store and online; evaluating, researching and developing new products for future distribution; and exploring new markets for its products. To view our products, visit: On behalf of the Board ofVITALITY PRODUCTS INC. "Cheryl A. Grant" (signed) __________________________________ Cheryl A. Grant, President & CEO Forward-Looking Information Information set forth in this news release involves forward-looking statements. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address a company's expected future business and financial performance, and often contain words such as "anticipate", "believe", "plan", "estimate", "expect", and "intend", statements that an action or event "may", "might", "could", "should", or "will" be taken or occur, or other similar expressions. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following risks: risks associated with marketing and sale of securities; the need for additional financing; reliance on key personnel; the potential for conflicts of interest among certain officers or directors with certain other projects; and the volatility of common share price and volume. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date that statements are made and except as required by law, the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Investors are cautioned against attributing undue certainty to forward-looking statements. THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF THE DATE OF THIS NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE SECURITIES LEGISLATION. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. SOURCE Vitality Products Inc. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Time Business News
35 minutes ago
- Time Business News
Social Media Addiction and Its Mental Health Impacts
In the digital age, social media platforms like Instagram, TikTok, Facebook, Twitter, and Snapchat have become deeply embedded in our daily lives. They offer instant connectivity, entertainment, and even professional networking. But as our screen time rises, so does a growing concern: social media addiction. What starts as a harmless scroll can evolve into a compulsive habit with serious implications for mental health. Path to Recovery Overcoming dependency requires a comprehensive approach that addresses both physical and emotional challenges. Individuals often face withdrawal symptoms and cravings that can be overwhelming without proper guidance. Support from healthcare professionals, family, and community plays a crucial role in fostering resilience. Behavioral therapies and counseling help uncover underlying causes and teach coping mechanisms. In the middle of these efforts, Drug Addiction Treatment becomes essential to stabilize and guide the patient through detoxification and rehabilitation. Continued care and relapse prevention strategies ensure long-term success, empowering individuals to rebuild their lives with renewed hope and strength. Social media addiction is characterized by excessive and compulsive use of social networking sites, often at the expense of real-life responsibilities, relationships, and well-being. While not yet formally recognized as a clinical disorder in the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders), it shares similar features with other behavioral addictions, such as gambling. Individuals may feel anxious or irritable when not online, find it hard to cut down on usage, or neglect important aspects of life like work, studies, or family. Social media platforms are designed to be addictive. They use sophisticated algorithms to capture attention and keep users engaged. Features like infinite scrolling, notifications, likes, and shares provide intermittent rewards that activate the brain's dopamine system—the same system involved in other addictive behaviors. Moreover, the fear of missing out (FOMO) plays a significant psychological role. Users often feel compelled to stay constantly updated to avoid missing out on trending content, conversations, or social events. This fear can trap individuals in an endless cycle of checking and refreshing their feeds. The link between social media and mental health is complex. While these platforms can offer support and community, excessive use often correlates with increased rates of depression, anxiety, loneliness, and low self-esteem. Multiple studies have found a strong association between high social media use and symptoms of depression and anxiety. One reason is social comparison. Users often compare their real lives to the curated highlight reels of others. Seeing friends or influencers living seemingly perfect lives can lead to feelings of inadequacy, failure, and sadness. These comparisons can be especially harmful to teenagers and young adults, who are more vulnerable to external validation. Screen time—especially before bed—has been linked to disrupted sleep patterns. Blue light from devices can interfere with melatonin production, making it harder to fall and stay asleep. In addition, the mental stimulation from scrolling through content or engaging in online conversations can make it difficult to wind down. Poor sleep quality further exacerbates mental health issues such as depression, anxiety, and stress. Platforms like Instagram and TikTok emphasize visuals, making them hotspots for body image concerns. Filters, editing apps, and influencer culture set unrealistic beauty standards. As users strive to emulate these ideals, they may develop negative self-perceptions. This is particularly harmful to adolescents, who are still developing their identities and self-worth. Paradoxically, while social media is designed to connect us, it can also lead to feelings of loneliness. Online interactions often lack the depth and emotional fulfillment of face-to-face communication. Relying solely on digital connections may result in social withdrawal and reduced participation in real-world relationships. Constant notifications and the habit of multitasking between apps can reduce our attention span and productivity. Social media can interrupt work or study sessions, making it harder to focus and leading to feelings of stress or inadequacy when tasks remain unfinished. While anyone can be affected by social media addiction, certain groups are more vulnerable: Teenagers and Young Adults: This demographic is more impressionable and driven by peer approval. They're also among the heaviest users of social platforms. This demographic is more impressionable and driven by peer approval. They're also among the heaviest users of social platforms. People with Pre-existing Mental Health Issues: Those struggling with anxiety, depression, or low self-esteem may turn to social media for escape or validation. Those struggling with anxiety, depression, or low self-esteem may turn to social media for escape or validation. Individuals with Low Offline Social Support: People who lack strong real-world connections may seek solace online, making them more dependent on digital interactions. The goal isn't to demonize social media, but to promote healthier habits. Here are some strategies to maintain balance: Set Time Limits: Use screen time trackers or apps to monitor and limit usage. Create Tech-Free Zones: Establish boundaries, such as no phones at the dinner table or during bedtime. Curate Your Feed: Unfollow accounts that promote negativity or unrealistic standards. Follow content that inspires and uplifts. Engage Mindfully: Ask yourself why you're logging in—are you bored, lonely, or procrastinating? Finding healthier alternatives for these feelings can be beneficial. Take Regular Breaks: Digital detoxes, even short ones, can help reset your habits and improve mental clarity. Seek Professional Help: If social media use is interfering with daily life or causing significant distress, talking to a therapist or counselor can be helpful. Social media is a powerful tool—it can educate, connect, and entertain. But when used excessively, it can also be a source of anxiety, stress, and disconnection. Being mindful of how, when, and why we engage with these platforms is essential for protecting our mental health in an increasingly digital world. It's time to take back control and build a more balanced relationship with the online spaces we occupy. TIME BUSINESS NEWS
Yahoo
42 minutes ago
- Yahoo
Updated: Henry Schein to Participate in Upcoming Investor Conference in June
MELVILLE, N.Y., June 02, 2025--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in June: Jefferies Global Healthcare Conference at the Marriott Marquis hotel, New York City, on June 4, at 12:50 p.m. Eastern time. Henry Schein's presentations can be heard via live webcast by visiting Replays will be available on the Henry Schein website following the presentations. About Henry Schein, Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995. For more information, visit Henry Schein at and @HenrySchein on X. View source version on Contacts Investors Ronald N. SouthSenior Vice President and Chief Financial (631) 843-5500 Graham StanleyVice President, Investor Relations and Strategic Financial Project (631) 843-5500 Media Tim VassilakosExecutive Director, Global Corporate (516) 510-0926 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
